Clinical Trials on Adult Primary Hepatocellular Carcinoma in China

Total 1634 results

Lei Li

Completed

A Study on Association Between HR Genes and the HRD Status in Chinese Epithelial Ovarian Cancer

Epithelial Ovarian Cancer | BRCA1 Mutation | BRCA2 Mutation | Homologous Recombination Deficiency | Prognosis | Chinese | Homologous Recombination Genes

China
Peking Union Medical College Hospital

Unknown

Camrelizumab /Apatinib for Recurrent Platinum-resistant Ovarian Cancer

Recurrent Platinum-resistant Ovarian Cancer

China
Lei Li

Unknown

A Genomic Analysis of Evolution of Epithelia Ovarian Tumors

Epithelial Ovarian Cancer | Progression-free Survival | Epithelial Ovarian Tumor of Borderline Malignancy | Driving Mutations

China
West China Hospital
RemeGen Co., Ltd.

Not yet recruiting

RC48-ADC in Adjuvant/Salvage Treatment of HER2 Positive Non-muscle-invasive Bladder Cancer

Non-muscle Invasive Bladder Cancer

China
RenJi Hospital
BeiGene; RemeGen Co., Ltd.

Recruiting

RC48 Combined With Tislelizumab for Bladder Sparing Treatment in NMIBC With BCG Treatment Failure and HER2 Expression

HER2 | Non-Muscle Invasive Bladder Cancer

China
Shenzhen Geno-Immune Medical Institute

Suspended

Intervention of Ovarian Cancer With Antigen-specific Engineered Immune Effectors

Ovarian Cancer

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Completed

A Bioequivalence Study of Sunitinib Malate Capsules.

Renal Cell Carcinoma | Gastrointestinal Stromal Tumors | Pancreatic Neuroendocrine Tumor

China
Peking University First Hospital

Recruiting

Establishment of a Multidimensional Prediction Model for the Natural Course of VHL Disease-related Renal Cell Carcinoma

Renal Cell Carcinoma | VHL Syndrome

China
Shenzhen Geno-Immune Medical Institute

Unknown

Engineered Immune Effectors Against Ovarian Cancer

Ovarian Cancer

China
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co...

Completed

Assess Bioequivalence of Two Formulations of Doxorubicin Hydrochloride Liposome in Female Patients With Ovarian Cancer

Ovarian Cancer

China
Preventive Oncology International, Inc.
Peking University Shenzhen Hospital

Completed

Chinese Cancer Prevention Study(CHICAPS) (CHICAPS)

Cervical Cancer | Cervical Intraepithelial Neoplasia | Human Papillomavirus | Cervical Dysplasia | Cervical Neoplasm

China
Sichuan Cancer Hospital and Research Institute

Recruiting

A Cohort Establishment Study of Total Management of Ovarian Cancer

Ovarian Cancer | Tumor of Female Reproductive System

China
Lei Li

Recruiting

ctDNA Methylation for Detecting Ovarian Cancer

Epithelial Ovarian Cancer | Circulating Tumor DNA | CA125 | DNA Methylation | Non-invasive Diagnosis | Human Epididymis Protein 4 | Imaging Evaluation | Survival Prognosis | ROMA Index

China
Peking University Third Hospital

Not yet recruiting

Intraperitoneal Lidocaine in Ovarian Cancer Surgery

Ovarian Cancer | Post Operative Pain

China
Fudan University
BGI Tianjin

Recruiting

Bespoke ctDNA Assay for Recurrence and Treatment Response Monitoring in Advanced Epithelial Ovarian Cancer (EOC)

Ovarian Cancer

China
Lei Li

Unknown

A Multi-omics Study of Epithelial Ovarian Cancer

Epithelial Ovarian Cancer | Metabolomics | Transcriptomics | Whole Exome Sequencing | Tumor Invasiveness | Tumorigenesis

China
Jiangsu Simcere Pharmaceutical Co., Ltd.
Shanghai Xianxiang Medical Technology Co., Ltd.

Active, not recruiting

A Phase III Study of BD0801 Combined With Chemotherapy in Recurrent, Platinum-resistant Epithelial Ovarian Cancer

Ovarian Cancer

China
RenJi Hospital

Recruiting

Individualized Health Management of Epithelial Ovarian Cancer: A Retrospective Study

Epithelial Ovarian Cancer

China
Lei Li

Recruiting

ctDNA Methylation for Epithelial Ovarian Cancer

Epithelial Ovarian Cancer | Circulating Tumor DNA | CA125 | DNA Methylation | Non-invasive Diagnosis | Human Epididymis Protein 4 | Imaging Evaluation | Survival Prognosis

China
Chongqing University Cancer Hospital

Recruiting

The Culture of Ovarian Cancer Organoids and Drug Screening

Ovarian Cancer

China
Chongqing University Cancer Hospital
Zhejiang Cancer Hospital; Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University and other collaborators

Completed

Diagnosis of Epithelial Ovarian Cancer Using Ovarian Cancer Score (OCS) Test

Epithelial Ovarian Cancer | Adnexal Mass

China
Women's Hospital School Of Medicine Zhejiang University

Recruiting

Study on the Dynamic Changes of Metabolic Biomarkers and Their Prognostic Relationship in Ovarian Cancer

Ovarian Cancer

China
Tongji Hospital
National Natural Science Foundation of China

Not yet recruiting

Diagnostic Cervical Conization for Persistent Infection or Integration of HPV

Cervical Cancer | Cervical Intraepithelial Neoplasia | Human Papilloma Virus Infection | Human Papilloma Virus Integration | Cervical Conization

China
First Affiliated Hospital Xi'an Jiaotong University

Enrolling by invitation

Efficacy and Adverse Effects of Olaparib in Ovarian Cancer.

Ovarian Cancer

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

Phase II Study of Anlotinib in Patients With Advanced Renal Cell Carcinoma That Have Failed Or Are Intolerant To TKIs Therapy

Renal Cell Carcinoma

China
The Cleveland Clinic
National Cancer Institute (NCI); University of Southern California; Medical College... and other collaborators

Active, not recruiting

Comparison of Cervical CIN II/III Treatment Outcomes With Thermal Ablation Device

Cervical Intraepithelial Neoplasia

China, El Salvador
Shenzhen Second People's Hospital
Shenzhen Institute for Innovation and Translational Medicine

Unknown

T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies

Melanoma | Breast Cancer | Multiple Myeloma | Ovarian Cancer | Lung Cancer | Neuroblastoma | Bladder Carcinoma | Synovial Sarcoma | Esophagus Carcinoma | Other Metastatic Solid Cancers

China
Sun Yat-sen University

Unknown

A Study of Anti-PD-1 Combinations of D-CIK Immunotherapy and Axitinib in Advanced Ranal Carcinoma

Renal Cancer Metastatic

China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Zai Lab (Shanghai) Co., Ltd.; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Completed

Anlotinib Combined With Niraparib Dual Therapy in Platinum-resistant Recurrent Ovarian Clear Cell Carcinoma. (CC-ANNIE)

Platinum-resistant Recurrent Clear Cell Ovarian Cancer

China
Hospital Universitari de Bellvitge

Unknown

Circulating Lymphatic Progenitor Cell and Lymph Node Metastasis

Ovarian Cancer

China
Anhui Provincial Cancer Hospital

Recruiting

An Exploratory Clinical Study of Statins for Improving Chemotherapy and Maintenance in Patients With Ovarian Cancer

Ovarian Cancer

China
Anhui Provincial Cancer Hospital
Hutchison Medipharma Limited

Recruiting

Surufatinib Combined With Carboplatin/Paclitaxel and Surufatinib Combined With Olaparib as First-line and Maintenance Therapy for Newly Diagnosed High-risk Ovarian Cancer

Ovarian Cancer

China
Anhui Provincial Cancer Hospital
Anhui Kecheng intelligent health technology Co., LTD

Recruiting

Safety and Efficacy of Intraperitoneal Injection of METR-NK Cells as Neoadjuvant Therapy for Advanced Epithelial Ovarian Cancer

Ovarian Cancer

China
Bai-Rong Xia

Active, not recruiting

Pamiparib Combined With Surufatinib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer

Ovarian Cancer

China
Chongqing Precision Biotech Co., Ltd

Recruiting

A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-T

Renal Cell Carcinoma | Ovarian Cancer | Cervix Cancer | Advanced Solid Tumor | Metastatic Tumor

China
Guangdong Association of Clinical Trials

Not yet recruiting

Lorlatinib in Patients With ALK-Positive NSCLC With Brain or Leptomeningeal Metastases

Carcinoma, Non-Small-Cell Lung | Brain Metastases | Leptomeningeal Metastasis

China
Huazhong University of Science and Technology

Recruiting

The Prognostic Impact of Tumor Location in Non-Muscle-Invasive Bladder Cancer Patients

Bladder Cancer | Non-Muscle-Invasive Bladder Cancer

China
Xinhua Hospital, Shanghai Jiao Tong University...

Recruiting

CtDNA as a Novel Biomarker of Treatment Efficacy in Patients With Ovarian Cancer

High-grade Serous Ovarian Cancer | Circulating Tumor DNA

China
Jiangsu HengRui Medicine Co., Ltd.
Peking University Cancer Hospital & Institute

Completed

A Study of Fluzoparib Given in Combination With Apatinib in Ovarian or Breast Cancer Patients

Ovarian Cancer | Triple Negative Breast Cancer

China
The First Affiliated Hospital with Nanjing Medical...

Recruiting

The Necessity of a Second Transurethral Resection in High-risk Non-muscle-invasive Bladder Cancer Patients With Negative Urine Biomarker After Initial Transurethral Resection

Non Muscle Invasive Bladder Cancer

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus Paclitaxel as Weekly Treatment of Relapsed Platinum-resistant Ovarian Cancer

Recurrent Platinum-resistant Ovarian Cancer

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

Phase II Study of Anlotinib Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma（RCC）

Anlotinib | RCC

China
Shanghai Zhongshan Hospital

Recruiting

Determine the Effects of Prone Positioning and NO in COVID-19 ARDS by EIT

COVID-19 | Respiratory Distress Syndrome, Adult

China
Weijia Fang, MD
Chongqing Precision Biotech Co., Ltd

Recruiting

A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

Renal Cell Carcinoma | Ovarian Cancer | Cervix Cancer | Advanced Solid Tumor | Metastatic Tumor

China
Chongqing Precision Biotech Co., Ltd

Recruiting

A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

Renal Cell Carcinoma | Ovarian Cancer | Cervix Cancer | Advanced Solid Tumor | Metastatic Tumor

China
Peking Union Medical College Hospital

Recruiting

A Real-World Patient-Reported Outcomes Study in Patients With Long-Term Use of Niraparib

Ovarian Cancer

China
Chipscreen Biosciences, Ltd.

Recruiting

Chiauranib Plus Weekly Paclitaxel in Patients With Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer (CHIPRO)

Ovarian Cancer | Relapsed or Refractory | Chiauranib | Paclitaxel

China
RenJi Hospital

Recruiting

Stereotactic Body Radiation Therapy for Spinal Metastases in Favorite Tumors

Breast Cancer | Prostate Cancer | Non Small Cell Lung Cancer

China
National Cancer Institute (NCI)
NRG Oncology

Active, not recruiting

Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Seromucinous Carcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Primary Peritoneal High Grade Serous Adenocarcinoma | Ovarian High Grade Serous Adenocarcinoma | Fallopian... and other conditions

United States, Puerto Rico
Luo Chengyan

Recruiting

Effect of Early Enteral Nutrition on Postoperative Recovery of Ovarian Cancer Patients

Advanced Epithelial Ovarian Cancer

China

Clinical Trials on Adult Primary Hepatocellular Carcinoma in China

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Papua New Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations